What is the appropriate emergency department management for a 42-year-old male with type 1 diabetes mellitus and gastroparesis presenting with severe vomiting, beta‑hydroxybutyrate 4.3 mmol/L, glucose 344 mg/dL, pH 7.44, lactate 5.3 mmol/L, and leukocytosis (WBC 16.1 ×10⁹/L)?

Emergency Management: Euglycemic Diabetic Ketoacidosis with Gastroparesis Exacerbation

This patient has euglycemic diabetic ketoacidosis (euDKA) complicated by gastroparesis and requires immediate insulin infusion, aggressive IV fluid resuscitation, and treatment of the underlying gastroparesis with metoclopramide or erythromycin while addressing the elevated lactate and potential sepsis.

Critical Laboratory Interpretation

The laboratory values reveal a dangerous metabolic picture that demands immediate recognition:

• Beta-hydroxybutyrate 4.3 mmol/L = significant ketosis (normal <0.6)
• Glucose 344 mg/dL = elevated but NOT severely hyperglycemic (typical DKA >400-600)
• pH 7.44 = paradoxically alkalotic despite ketoacidosis
• Lactate 5.3 mmol/L = significantly elevated, concerning for tissue hypoperfusion or sepsis
• WBC 16.1 = leukocytosis suggesting infection or stress response

This is euglycemic DKA masked by metabolic alkalosis from severe vomiting 1. The normal-to-alkalotic pH does NOT exclude DKA when beta-hydroxybutyrate is elevated with an appropriate clinical picture. The profuse vomiting from gastroparesis has created a mixed acid-base disturbance where the metabolic alkalosis (from gastric acid loss and volume depletion) is masking the expected acidosis from ketone production 1.

Immediate ED Management Algorithm

Step 1: Fluid Resuscitation (First Priority)

• Start aggressive IV fluid resuscitation immediately with 0.9% normal saline at 15-20 mL/kg/hour (approximately 1-1.5 L in first hour) 2
• The elevated lactate (5.3) indicates significant volume depletion and possible tissue hypoperfusion
• Reassess hemodynamics after initial bolus and adjust rate accordingly
• Monitor for fluid overload, though unlikely given severe vomiting and dehydration

Step 2: Insulin Therapy (Concurrent with Fluids)

• Begin continuous IV insulin infusion at 0.1 units/kg/hour (standard DKA protocol) 2
• Do NOT wait for acidosis to appear on pH—the elevated beta-hydroxybutyrate defines the ketotic state
• Add dextrose (D5 or D10) to IV fluids when glucose drops below 250 mg/dL to prevent hypoglycemia while continuing insulin to clear ketones 2, 3
• This is critical: insulin must continue until beta-hydroxybutyrate normalizes, regardless of glucose level

Step 3: Antiemetic and Prokinetic Therapy

Start metoclopramide 10 mg IV immediately 4. This serves dual purposes:

• Treats acute gastroparesis exacerbation causing the vomiting
• Acts as antiemetic to break the vomiting cycle
• Metoclopramide is the only FDA-approved agent for gastroparesis and has conditional recommendation from 2025 AGA guidelines 4

Alternative: Erythromycin 250 mg IV if metoclopramide contraindicated or ineffective 4

Add ondansetron 4-8 mg IV for additional antiemetic coverage without affecting gastric emptying 4

Step 4: Electrolyte Management

• Check potassium immediately and begin replacement when <5.3 mEq/L (before starting insulin if possible) 2
• Add 20-30 mEq potassium to each liter of IV fluid once urine output established
• Monitor potassium every 2-4 hours—insulin will drive potassium intracellularly
• Phosphate replacement only if <1.0 mg/dL to avoid respiratory depression 2

Step 5: Address Potential Sepsis

The combination of WBC 16.1, elevated lactate 5.3, and vomiting raises concern for:

• Aspiration pneumonia (common with severe gastroparesis and vomiting)
• Intra-abdominal infection (gastroparesis can rarely progress to gastric necrosis) 5
• Urinary tract infection or other occult infection

Obtain:

• Blood cultures × 2
• Urinalysis and urine culture
• Chest X-ray to evaluate for aspiration
• Consider CT abdomen if abdominal pain or peritoneal signs present (gastroparesis can rarely cause gastric perforation) 5

Start empiric broad-spectrum antibiotics (e.g., ceftriaxone 1-2g IV + metronidazole 500mg IV) if sepsis suspected based on clinical presentation, pending cultures

Monitoring Parameters

Every 1-2 hours initially:

• Capillary glucose
• Electrolytes (especially potassium)
• Venous pH and anion gap (arterial blood gases unnecessary) 2

Every 4 hours:

• Beta-hydroxybutyrate (the TRUE marker of ketosis resolution—nitroprusside urine ketones are misleading) 2
• Lactate (should trend down with resuscitation)

Resolution Criteria

DKA is resolved when ALL of the following are met 2:

• Beta-hydroxybutyrate <1.0 mmol/L (or normalized)
• Glucose <200 mg/dL
• Anion gap normalized
• Patient tolerating oral intake

Do NOT stop insulin infusion based on pH alone—this patient's pH was never acidotic to begin with due to the mixed disorder 1.

Critical Pitfalls to Avoid

1. Dismissing DKA because pH is normal/alkalotic: The elevated beta-hydroxybutyrate with appropriate clinical context defines ketoacidosis regardless of pH 1. Severe vomiting creates metabolic alkalosis that masks the acidosis.

2. Stopping insulin when glucose normalizes: Continue insulin infusion with dextrose supplementation until ketones clear 2, 3. Premature insulin discontinuation will perpetuate ketogenesis.

3. Ignoring the elevated lactate: Lactate 5.3 is significantly elevated and demands investigation for sepsis, tissue hypoperfusion, or both. This is NOT simply from DKA.

4. Inadequate fluid resuscitation: Severe vomiting from gastroparesis causes profound volume depletion. The elevated lactate confirms this.

5. Overlooking gastroparesis as the precipitant: The gastroparesis exacerbation likely triggered this entire cascade by causing vomiting, poor oral intake, and metabolic derangement. Treating only the DKA without addressing gastroparesis will lead to recurrence 6.

6. Using urine ketones to monitor treatment: Nitroprusside-based tests detect acetoacetate but not beta-hydroxybutyrate (the predominant ketone body). As DKA improves, beta-hydroxybutyrate converts to acetoacetate, making urine ketones APPEAR to worsen despite clinical improvement 2.

Disposition

Admit to ICU for:

• Continuous insulin infusion
• Close metabolic monitoring
• Evaluation and treatment of potential sepsis
• Management of severe gastroparesis exacerbation

Transition to subcutaneous insulin only after:

• Ketones cleared
• Patient tolerating oral intake
• Continue IV insulin for 1-2 hours AFTER first subcutaneous dose to prevent rebound hyperglycemia 2

Long-term Considerations

This patient will need:

• Optimization of diabetes control to prevent recurrent DKA
• Ongoing gastroparesis management with metoclopramide or erythromycin 4
• Dietary modifications (small-particle, low-fat, low-residue diet) 4
• Possible advanced therapies if refractory (G-POEM, gastric electrical stimulation) 4
• Education about recognizing early signs of decompensation

The combination of T1DM with gastroparesis creates a vicious cycle where gastroparesis impairs glucose control, and poor glucose control worsens gastroparesis 6, 7. Breaking this cycle requires aggressive management of both conditions simultaneously.